speb/financial-data huggingface dataset:
SCYR.MC cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 409441000.00
SCYR.MC income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 233640000.00
SCYR.MC income_statement (annual, 2025-12-31) — Net Interest Income: -608845000.00
SCYR.MC cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -452262000.00
SCYR.MC cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 336720000.00
SCYR.MC cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 336720000.00
SCYR.MC income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -608845000.00
SCYR.MC cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 15506000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Net PPE: 446303000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Net PPE: 446303000.00
SCYR.MC cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -241634000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 955028000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 955028000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 37620000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 37620000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 939171000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 939171000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1092990000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1092990000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 8301000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 8301000.00
SCYR.MC income_statement (annual, 2025-12-31) — Normalized EBITDA: 1394846000.00
SCYR.MC income_statement (annual, 2025-12-31) — Normalized Income: 156794500.00
SCYR.MC cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1358605000.00
SCYR.MC income_statement (annual, 2025-12-31) — Operating Income: 1141315000.00
SCYR.MC income_statement (annual, 2025-12-31) — Operating Revenue: 4659539000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 770798429.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 770798429.00
SCYR.MC cash_flow (annual, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: -775000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Other Current Assets: 86136000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 86136000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Other Equity Interest: 110000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 110000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 75255000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 75255000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Other Inventories: 18732000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Other Inventories: 18732000.00
SCYR.MC cash_flow (annual, 2025-12-31) — Other Non Cash Items: -182489000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 73090000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 73090000.00
SCYR.MC income_statement (annual, 2025-12-31) — Other Operating Expenses: 1457196000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Other Payable: 492024000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Other Payable: 492024000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Other Properties: 276106000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Other Properties: 276106000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Other Receivables: 1814078000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1814078000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 39981000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 39981000.00
SCYR.MC income_statement (annual, 2025-12-31) — Other Special Charges: 81774000.00
SCYR.MC income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Payables: 3406367000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Payables: 3406367000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 57809000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 57809000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Prepaid Assets: 38351000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 38351000.00
SCYR.MC income_statement (annual, 2025-12-31) — Pretax Income: 409441000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Properties: 0.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
SCYR.MC cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 32407000.00
SCYR.MC cash_flow (annual, 2025-12-31) — Purchase Of Investment: -578646000.00
SCYR.MC cash_flow (annual, 2025-12-31) — Purchase Of PPE: -255053000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Raw Materials: 61731000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Raw Materials: 61731000.00
SCYR.MC income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1522054000.00
SCYR.MC income_statement (annual, 2025-12-31) — Reconciled Depreciation: 184480000.00
SCYR.MC cash_flow (annual, 2025-12-31) — Repayment Of Debt: -2003911000.00
SCYR.MC cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -196000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Retained Earnings: 85787000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 85787000.00
SCYR.MC cash_flow (annual, 2025-12-31) — Sale Of Investment: 126384000.00
SCYR.MC cash_flow (annual, 2025-12-31) — Sale Of PPE: 13419000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Share Issued: 776857778.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Share Issued: 776857778.00
SCYR.MC income_statement (annual, 2025-12-31) — Special Income Charges: -82394000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1040326000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1040326000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Tangible Book Value: 955028000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 955028000.00
SCYR.MC income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -23462500.00
SCYR.MC income_statement (annual, 2025-12-31) — Tax Provision: 175801000.00
SCYR.MC income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.25
SCYR.MC cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -52632000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Total Assets: 17571110000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Total Assets: 17571110000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Total Capitalization: 9003563000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 9003563000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Total Debt: 9347476000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Total Debt: 9347476000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2202717000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2202717000.00
SCYR.MC income_statement (annual, 2025-12-31) — Total Expenses: 3518224000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 15368393000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 15368393000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 11768823000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 11768823000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 10322559000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 10322559000.00
SCYR.MC income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 1088501000.00
SCYR.MC income_statement (annual, 2025-12-31) — Total Other Finance Cost: -33996000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Total Tax Payable: 195944000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 195944000.00
SCYR.MC income_statement (annual, 2025-12-31) — Total Unusual Items: -93230000.00
SCYR.MC income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -93850000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 887854000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 887854000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 6059349.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 6059349.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Treasury Stock: 18476000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 18476000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Work In Process: 1583000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Work In Process: 1583000.00
SCYR.MC balance_sheet (annual, 2025-12-31) — Working Capital: 756453000.00
SCYR.MC balance_sheet (quarterly, 2025-12-31) — Working Capital: 756453000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — +Operating Expense: 895462000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — +Total Revenue: 1116346000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2648403000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3758506000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 7476000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Basic Average Shares: 799720793.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Basic EPS: 0.05
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 109428000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2118966000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2203488000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 998933000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Current Assets: 6169810000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 32977000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Current Debt: 1430994000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1463971000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 5239348000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Current Provisions: 190282000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 61072000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 61072000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 104390000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 799720793.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.05
SCYR.MC income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 37517000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — EBIT: 220884000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — EBITDA: 281956000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Goodwill: 7122000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 83364000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Gross PPE: 439748000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 29300000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Inventory: 171040000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Invested Capital: 9923261000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Investment Properties: 2172715000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 1404900000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 76451000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 7493334000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 7569785000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 171304000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Minority Interest: 1173200000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Minority Interests: -29484000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Net Debt: 6805362000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Net Income: 37517000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 37517000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 67001000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 37517000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 37517000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 67001000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Net Interest Income: -141437000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -141437000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Net PPE: 439748000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 915569000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 261819000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Normalized Income: 24777408.88
SCYR.MC income_statement (quarterly, 2026-03-31) — Operating Income: 220884000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Operating Revenue: 1116346000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 799720793.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 903826000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 76242000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 69424000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 2757270000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 930227000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Other Properties: 439748000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 84522000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Other Special Charges: -3708000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Payables: 2648403000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Pretax Income: 105906000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 61072000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Share Issued: 805780142.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Special Income Charges: 3708000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 998933000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 915569000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 7397408.88
SCYR.MC income_statement (quarterly, 2026-03-31) — Tax Provision: 38905000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.37
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Total Assets: 18014230000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 8492267000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Total Debt: 9033756000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2172133000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Total Expenses: 895462000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 15842097000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 11844420000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 10602749000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 232598000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Total Unusual Items: 20137000.00
SCYR.MC income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 20137000.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 6059349.00
SCYR.MC balance_sheet (quarterly, 2026-03-31) — Working Capital: 930462000.00
SCYX balance_sheet (annual, 2021-12-31) — Accounts Receivable: 861000.00
SCYX balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -467000.00
SCYX cash_flow (annual, 2021-12-31) — Capital Expenditure: -1172000.00
SCYX cash_flow (annual, 2021-12-31) — Change In Inventory: -5292000.00
SCYX cash_flow (annual, 2021-12-31) — Changes In Account Receivables: -861000.00
SCYX income_statement (annual, 2021-12-31) — Cost Of Revenue: 312000.00
SCYX cash_flow (annual, 2021-12-31) — Depreciation Amortization Depletion: 379000.00
SCYX cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 379000.00
SCYX balance_sheet (annual, 2021-12-31) — Finished Goods: 127000.00
SCYX balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 1056000.00
SCYX income_statement (annual, 2021-12-31) — Gross Profit: 12851000.00
SCYX balance_sheet (annual, 2021-12-31) — Inventory: 463000.00
SCYX cash_flow (annual, 2021-12-31) — Issuance Of Debt: 30000000.00
SCYX balance_sheet (annual, 2021-12-31) — Long Term Debt: 40352000.00
SCYX cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 30000000.00
SCYX balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 482000.00
SCYX cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: -1172000.00
SCYX cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: 0.00
SCYX balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 3345000.00
SCYX income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 13000.00
SCYX income_statement (annual, 2021-12-31) — Other Special Charges: 2725000.00
SCYX income_statement (annual, 2021-12-31) — Other Taxes: -13000.00
SCYX cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: -1172000.00
SCYX cash_flow (annual, 2021-12-31) — Purchase Of PPE: 0.00
SCYX balance_sheet (annual, 2021-12-31) — Raw Materials: 333000.00
SCYX income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 312000.00
SCYX income_statement (annual, 2021-12-31) — Reconciled Depreciation: 379000.00
SCYX income_statement (annual, 2021-12-31) — Special Income Charges: -2725000.00
SCYX balance_sheet (annual, 2021-12-31) — Work In Process: 3000.00
SCYX income_statement (annual, 2022-12-31) — +Operating Expense: 90220000.00
SCYX income_statement (annual, 2022-12-31) — +Total Revenue: 5091000.00
SCYX balance_sheet (annual, 2022-12-31) — Accounts Payable: 5937000.00
SCYX balance_sheet (annual, 2022-12-31) — Accounts Receivable: 2101000.00
SCYX balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 425485000.00
SCYX cash_flow (annual, 2022-12-31) — Amortization Of Securities: -309000.00
SCYX cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
SCYX income_statement (annual, 2022-12-31) — Basic Average Shares: 5326688.00
SCYX income_statement (annual, 2022-12-31) — Basic EPS: -11.76
SCYX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 104702000.00
SCYX cash_flow (annual, 2022-12-31) — Capital Expenditure: -9000.00
SCYX balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 3203000.00
SCYX balance_sheet (annual, 2022-12-31) — Capital Stock: 36000.00
SCYX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 45814000.00
SCYX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 73503000.00
SCYX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 48602000.00
SCYX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -27389000.00
SCYX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -79883000.00
SCYX cash_flow (annual, 2022-12-31) — Change In Account Payable: -1481000.00
SCYX cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -70000.00
SCYX cash_flow (annual, 2022-12-31) — Change In Inventory: -436000.00
SCYX cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 2355000.00
SCYX cash_flow (annual, 2022-12-31) — Change In Payable: -1481000.00
SCYX cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -1551000.00
SCYX cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 1636000.00
SCYX cash_flow (annual, 2022-12-31) — Change In Receivables: -1240000.00
SCYX cash_flow (annual, 2022-12-31) — Change In Working Capital: 764000.00
SCYX cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -1240000.00
SCYX cash_flow (annual, 2022-12-31) — Changes In Cash: -58670000.00
SCYX balance_sheet (annual, 2022-12-31) — Common Stock: 36000.00
SCYX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 3233000.00
SCYX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 47248000.00
SCYX income_statement (annual, 2022-12-31) — Cost Of Revenue: 628000.00
SCYX balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 3312000.00
SCYX balance_sheet (annual, 2022-12-31) — Current Assets: 79061000.00
SCYX balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 282000.00
SCYX balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 282000.00
SCYX balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 0.00
SCYX balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 0.00
SCYX balance_sheet (annual, 2022-12-31) — Current Liabilities: 17618000.00
SCYX cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 606000.00
SCYX cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 606000.00
SCYX balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 18644000.00
SCYX income_statement (annual, 2022-12-31) — Diluted Average Shares: 5326688.00
SCYX income_statement (annual, 2022-12-31) — Diluted EPS: -11.76
SCYX income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -62809000.00
SCYX income_statement (annual, 2022-12-31) — EBIT: -62311000.00
SCYX income_statement (annual, 2022-12-31) — EBITDA: -61705000.00
SCYX cash_flow (annual, 2022-12-31) — End Cash Position: 46032000.00
SCYX cash_flow (annual, 2022-12-31) — Financing Cash Flow: 48602000.00
SCYX balance_sheet (annual, 2022-12-31) — Finished Goods: 24000.00
SCYX cash_flow (annual, 2022-12-31) — Free Cash Flow: -79892000.00
SCYX cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -23617000.00
SCYX income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 23617000.00
SCYX balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 408000.00
SCYX balance_sheet (annual, 2022-12-31) — Gross PPE: 2594000.00
SCYX income_statement (annual, 2022-12-31) — Gross Profit: 4463000.00
SCYX balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 0.00
SCYX income_statement (annual, 2022-12-31) — Interest Expense: 5198000.00
SCYX income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 5198000.00
SCYX income_statement (annual, 2022-12-31) — Interest Income: 1415000.00
SCYX income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1415000.00
SCYX cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 5190000.00
SCYX balance_sheet (annual, 2022-12-31) — Inventory: 899000.00
SCYX balance_sheet (annual, 2022-12-31) — Invested Capital: 48627000.00
SCYX cash_flow (annual, 2022-12-31) — Investing Cash Flow: -27389000.00
SCYX balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 0.00
SCYX balance_sheet (annual, 2022-12-31) — Investments And Advances: 0.00
SCYX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 47248000.00
SCYX cash_flow (annual, 2022-12-31) — Issuance Of Debt: 5000000.00
SCYX balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 2921000.00
SCYX balance_sheet (annual, 2022-12-31) — Long Term Debt: 45394000.00
SCYX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 48315000.00
SCYX cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 5000000.00
SCYX cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
SCYX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 47248000.00
SCYX income_statement (annual, 2022-12-31) — Net Income: -62809000.00
SCYX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -62809000.00
SCYX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -62809000.00
SCYX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -62809000.00
SCYX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -62809000.00
SCYX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -62809000.00
SCYX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -62809000.00
SCYX cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -9000.00
SCYX income_statement (annual, 2022-12-31) — Net Interest Income: -5372000.00
SCYX cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -27380000.00
SCYX cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 5000000.00
SCYX cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 5000000.00
SCYX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -5372000.00
SCYX cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -3664000.00
SCYX balance_sheet (annual, 2022-12-31) — Net PPE: 2594000.00
SCYX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2825000.00
SCYX balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 73000.00
SCYX balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 0.00
SCYX balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 0.00
SCYX income_statement (annual, 2022-12-31) — Normalized EBITDA: -85322000.00
SCYX income_statement (annual, 2022-12-31) — Normalized Income: -84781776.27
SCYX cash_flow (annual, 2022-12-31) — Operating Cash Flow: -79883000.00
SCYX cash_flow (annual, 2022-12-31) — Operating Gains Losses: -23617000.00
SCYX income_statement (annual, 2022-12-31) — Operating Income: -85757000.00
SCYX income_statement (annual, 2022-12-31) — Operating Revenue: 5091000.00
SCYX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 4085292.00
SCYX balance_sheet (annual, 2022-12-31) — Other Current Assets: 62000.00
SCYX balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 5771000.00
SCYX income_statement (annual, 2022-12-31) — Other Income Expense: 23620000.00
SCYX cash_flow (annual, 2022-12-31) — Other Non Cash Items: 1796000.00
SCYX balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 5674000.00
SCYX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 3000.00
SCYX balance_sheet (annual, 2022-12-31) — Other Properties: 2594000.00
SCYX balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 27689000.00
SCYX balance_sheet (annual, 2022-12-31) — Payables: 5937000.00
SCYX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 9249000.00
SCYX balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2316000.00
SCYX balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
SCYX balance_sheet (annual, 2022-12-31) — Prepaid Assets: 2441000.00
SCYX income_statement (annual, 2022-12-31) — Pretax Income: -67509000.00
SCYX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 18000.00
SCYX cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -9000.00
SCYX cash_flow (annual, 2022-12-31) — Purchase Of Investment: -27380000.00
SCYX balance_sheet (annual, 2022-12-31) — Raw Materials: 265000.00
SCYX balance_sheet (annual, 2022-12-31) — Receivables: 2101000.00
SCYX income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 628000.00
SCYX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 606000.00
SCYX cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
SCYX income_statement (annual, 2022-12-31) — Research And Development: 27259000.00
SCYX balance_sheet (annual, 2022-12-31) — Restricted Cash: 55000.00
SCYX balance_sheet (annual, 2022-12-31) — Retained Earnings: -422288000.00
SCYX cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
SCYX income_statement (annual, 2022-12-31) — Selling General And Administration: 62961000.00
SCYX balance_sheet (annual, 2022-12-31) — Share Issued: 4085292.00
SCYX income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
SCYX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 3686000.00
SCYX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3233000.00
SCYX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2825000.00
SCYX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 1644223.73
SCYX income_statement (annual, 2022-12-31) — Tax Provision: -4700000.00
SCYX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.07
SCYX balance_sheet (annual, 2022-12-31) — Total Assets: 87810000.00
SCYX balance_sheet (annual, 2022-12-31) — Total Capitalization: 48627000.00
SCYX balance_sheet (annual, 2022-12-31) — Total Debt: 48597000.00
SCYX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3233000.00
SCYX income_statement (annual, 2022-12-31) — Total Expenses: 90848000.00
SCYX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 84577000.00
SCYX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 8749000.00
SCYX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 66959000.00
SCYX income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -85757000.00
SCYX income_statement (annual, 2022-12-31) — Total Other Finance Cost: 1589000.00
SCYX income_statement (annual, 2022-12-31) — Total Unusual Items: 23617000.00
SCYX income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 23617000.00
SCYX balance_sheet (annual, 2022-12-31) — Work In Process: 610000.00
SCYX balance_sheet (annual, 2022-12-31) — Working Capital: 61443000.00
SCYX income_statement (annual, 2023-12-31) — +Operating Expense: 51848000.00
SCYX income_statement (annual, 2023-12-31) — +Total Revenue: 140141000.00
SCYX balance_sheet (annual, 2023-12-31) — Accounts Payable: 7149000.00
SCYX balance_sheet (annual, 2023-12-31) — Accounts Receivable: 0.00
SCYX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 428169000.00
SCYX cash_flow (annual, 2023-12-31) — Amortization Of Securities: -1340000.00
SCYX cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 15354000.00
SCYX income_statement (annual, 2023-12-31) — Basic Average Shares: 5981604.00
SCYX income_statement (annual, 2023-12-31) — Basic EPS: 11.20
SCYX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 46032000.00
SCYX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 2921000.00
SCYX balance_sheet (annual, 2023-12-31) — Capital Stock: 40000.00
SCYX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 34050000.00
SCYX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 74362000.00
SCYX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -36721000.00
SCYX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -34877000.00
SCYX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 60159000.00
SCYX cash_flow (annual, 2023-12-31) — Change In Account Payable: 1172000.00
SCYX cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 1866000.00
SCYX cash_flow (annual, 2023-12-31) — Change In Inventory: -8849000.00
SCYX cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -6053000.00
SCYX cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 3916000.00
SCYX cash_flow (annual, 2023-12-31) — Change In Payable: 1172000.00
SCYX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 3038000.00
SCYX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -2971000.00
SCYX cash_flow (annual, 2023-12-31) — Change In Receivables: -19725000.00
SCYX cash_flow (annual, 2023-12-31) — Change In Working Capital: -30644000.00
SCYX cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 2101000.00
SCYX cash_flow (annual, 2023-12-31) — Changes In Cash: -11439000.00
SCYX balance_sheet (annual, 2023-12-31) — Common Stock: 40000.00
SCYX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 72962000.00
SCYX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 18000.00
SCYX income_statement (annual, 2023-12-31) — Cost Of Revenue: 15624000.00
SCYX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 5803000.00
SCYX balance_sheet (annual, 2023-12-31) — Current Assets: 102116000.00
SCYX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 340000.00
SCYX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 340000.00
SCYX balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 1189000.00
SCYX balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 1189000.00
SCYX balance_sheet (annual, 2023-12-31) — Current Liabilities: 16303000.00
SCYX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 580000.00
SCYX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 580000.00
SCYX balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 21680000.00
SCYX income_statement (annual, 2023-12-31) — Diluted Average Shares: 6048822.00
SCYX income_statement (annual, 2023-12-31) — Diluted EPS: 11.12
SCYX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 67041000.00
SCYX income_statement (annual, 2023-12-31) — EBIT: 70309000.00
SCYX income_statement (annual, 2023-12-31) — EBITDA: 70889000.00
SCYX cash_flow (annual, 2023-12-31) — End Cash Position: 34593000.00
SCYX cash_flow (annual, 2023-12-31) — Financing Cash Flow: -36721000.00
SCYX balance_sheet (annual, 2023-12-31) — Finished Goods: 0.00
SCYX cash_flow (annual, 2023-12-31) — Free Cash Flow: 60159000.00
SCYX cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 3320000.00
SCYX income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -3320000.00
SCYX balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 0.00
SCYX balance_sheet (annual, 2023-12-31) — Gross PPE: 2364000.00
SCYX income_statement (annual, 2023-12-31) — Gross Profit: 124517000.00
SCYX balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 23594000.00
SCYX income_statement (annual, 2023-12-31) — Interest Expense: 3130000.00
SCYX income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 3130000.00
SCYX income_statement (annual, 2023-12-31) — Interest Income: 3954000.00
SCYX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 3954000.00
SCYX cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 3248000.00
SCYX balance_sheet (annual, 2023-12-31) — Inventory: 0.00
SCYX balance_sheet (annual, 2023-12-31) — Invested Capital: 85121000.00
SCYX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -34877000.00
SCYX balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 23594000.00
SCYX balance_sheet (annual, 2023-12-31) — Investments And Advances: 23594000.00
SCYX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 18000.00
SCYX cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
SCYX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 2581000.00
SCYX balance_sheet (annual, 2023-12-31) — Long Term Debt: 12159000.00
SCYX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 14740000.00
SCYX cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
SCYX cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -36646000.00
SCYX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 18000.00
SCYX income_statement (annual, 2023-12-31) — Net Income: 67041000.00
SCYX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 67041000.00
SCYX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 67041000.00
SCYX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 67041000.00
SCYX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 67041000.00
SCYX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 67041000.00
SCYX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 67041000.00
SCYX cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
SCYX income_statement (annual, 2023-12-31) — Net Interest Income: -2170000.00
SCYX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -34877000.00
SCYX cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -36646000.00
SCYX cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -36646000.00
SCYX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -2170000.00
SCYX cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -135000.00
SCYX balance_sheet (annual, 2023-12-31) — Net PPE: 2364000.00
SCYX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 72962000.00
SCYX balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 175000.00
SCYX balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 2727000.00
SCYX balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 2727000.00
SCYX income_statement (annual, 2023-12-31) — Normalized EBITDA: 74209000.00
SCYX income_statement (annual, 2023-12-31) — Normalized Income: 70357680.00
SCYX cash_flow (annual, 2023-12-31) — Operating Cash Flow: 60159000.00
SCYX cash_flow (annual, 2023-12-31) — Operating Gains Losses: 3320000.00
SCYX income_statement (annual, 2023-12-31) — Operating Income: 72669000.00
SCYX income_statement (annual, 2023-12-31) — Operating Revenue: 140141000.00
SCYX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 4650974.00
SCYX balance_sheet (annual, 2023-12-31) — Other Current Assets: 4906000.00
SCYX balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 130000.00
SCYX income_statement (annual, 2023-12-31) — Other Income Expense: -3320000.00
SCYX cash_flow (annual, 2023-12-31) — Other Non Cash Items: 3224000.00
SCYX balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 163000.00
SCYX balance_sheet (annual, 2023-12-31) — Other Properties: 2364000.00
SCYX balance_sheet (annual, 2023-12-31) — Other Receivables: 21826000.00
SCYX balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 40312000.00
SCYX balance_sheet (annual, 2023-12-31) — Payables: 7149000.00
SCYX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 12952000.00
SCYX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1692000.00
SCYX balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
SCYX balance_sheet (annual, 2023-12-31) — Prepaid Assets: 642000.00
SCYX income_statement (annual, 2023-12-31) — Pretax Income: 67179000.00
SCYX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 42000.00
SCYX cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
SCYX cash_flow (annual, 2023-12-31) — Purchase Of Investment: -85480000.00
SCYX balance_sheet (annual, 2023-12-31) — Raw Materials: 0.00
SCYX balance_sheet (annual, 2023-12-31) — Receivables: 21826000.00
SCYX income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 15624000.00
SCYX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 580000.00
SCYX cash_flow (annual, 2023-12-31) — Repayment Of Debt: -36646000.00
SCYX income_statement (annual, 2023-12-31) — Research And Development: 30928000.00
SCYX balance_sheet (annual, 2023-12-31) — Restricted Cash: 380000.00
SCYX balance_sheet (annual, 2023-12-31) — Retained Earnings: -355247000.00
SCYX cash_flow (annual, 2023-12-31) — Sale Of Investment: 50603000.00
SCYX income_statement (annual, 2023-12-31) — Selling General And Administration: 20920000.00
SCYX balance_sheet (annual, 2023-12-31) — Share Issued: 4650974.00
SCYX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 2624000.00
SCYX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 72962000.00
SCYX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 72962000.00
SCYX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -3320.00
SCYX income_statement (annual, 2023-12-31) — Tax Provision: 138000.00
SCYX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
SCYX balance_sheet (annual, 2023-12-31) — Total Assets: 128412000.00
SCYX balance_sheet (annual, 2023-12-31) — Total Capitalization: 85121000.00
SCYX balance_sheet (annual, 2023-12-31) — Total Debt: 15080000.00
SCYX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 72962000.00
SCYX income_statement (annual, 2023-12-31) — Total Expenses: 67472000.00
SCYX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 55450000.00
SCYX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 26296000.00
SCYX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 39147000.00
SCYX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 72669000.00
SCYX income_statement (annual, 2023-12-31) — Total Other Finance Cost: 2994000.00
SCYX income_statement (annual, 2023-12-31) — Total Unusual Items: -3320000.00
SCYX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -3320000.00
SCYX balance_sheet (annual, 2023-12-31) — Work In Process: 0.00
SCYX balance_sheet (annual, 2023-12-31) — Working Capital: 85813000.00
SCYX cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
SCYX income_statement (quarterly, 2024-09-30) — Average Dilution Earnings: 0.00
SCYX income_statement (quarterly, 2024-09-30) — Basic Average Shares: 6077336.00
SCYX income_statement (quarterly, 2024-09-30) — Basic EPS: -0.48
SCYX cash_flow (quarterly, 2024-09-30) — Change In Inventory: 0.00
SCYX cash_flow (quarterly, 2024-09-30) — Change In Other Working Capital: -109000.00
SCYX cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: 0.00
SCYX cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
SCYX income_statement (quarterly, 2024-09-30) — Cost Of Revenue: 0.00
SCYX balance_sheet (quarterly, 2024-09-30) — Current Debt: 13225000.00
SCYX cash_flow (quarterly, 2024-09-30) — Depreciation Amortization Depletion: 0.00
SCYX cash_flow (quarterly, 2024-09-30) — Depreciation And Amortization: 0.00
SCYX income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 6077336.00
SCYX income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.48
SCYX income_statement (quarterly, 2024-09-30) — Gross Profit: 660000.00
SCYX cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
SCYX cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: 0.00
SCYX cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
SCYX cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
SCYX balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 13225000.00
SCYX balance_sheet (quarterly, 2024-09-30) — Other Receivables: 9662000.00
SCYX income_statement (quarterly, 2024-09-30) — Reconciled Cost Of Revenue: 0.00
SCYX income_statement (quarterly, 2024-09-30) — Reconciled Depreciation: 0.00
SCYX income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: 441000.00
SCYX income_statement (annual, 2024-12-31) — +Operating Expense: 40863000.00
SCYX income_statement (annual, 2024-12-31) — +Total Revenue: 3746000.00
SCYX balance_sheet (annual, 2024-12-31) — Accounts Payable: 4569000.00
SCYX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 431571000.00
SCYX cash_flow (annual, 2024-12-31) — Amortization Of Securities: -1340000.00
SCYX cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
SCYX cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
SCYX income_statement (annual, 2024-12-31) — Basic Average Shares: 6064134.00
SCYX income_statement (annual, 2024-12-31) — Basic EPS: -3.52
SCYX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 34593000.00
SCYX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 2582000.00
SCYX balance_sheet (annual, 2024-12-31) — Capital Stock: 41000.00
SCYX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 16051000.00
SCYX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 59300000.00
SCYX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -139000.00
SCYX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 6150000.00
SCYX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -24009000.00
SCYX cash_flow (annual, 2024-12-31) — Change In Account Payable: -2650000.00
SCYX cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -3701000.00
SCYX cash_flow (annual, 2024-12-31) — Change In Inventory: 0.00
SCYX cash_flow (quarterly, 2024-12-31) — Change In Inventory: 0.00
SCYX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -339000.00
SCYX cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -979000.00
SCYX cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: 0.00
SCYX cash_flow (annual, 2024-12-31) — Change In Payable: -2650000.00
SCYX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -6351000.00
SCYX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 3388000.00
SCYX cash_flow (annual, 2024-12-31) — Change In Receivables: 11564000.00
SCYX cash_flow (annual, 2024-12-31) — Change In Working Capital: 7283000.00
SCYX cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 0.00
SCYX cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: 0.00
SCYX cash_flow (annual, 2024-12-31) — Changes In Cash: -17998000.00
SCYX balance_sheet (annual, 2024-12-31) — Common Stock: 41000.00
SCYX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 55077000.00
SCYX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
SCYX cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
SCYX income_statement (annual, 2024-12-31) — Cost Of Revenue: 0.00
SCYX income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 0.00
SCYX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 2030000.00
SCYX balance_sheet (annual, 2024-12-31) — Current Assets: 72181000.00
SCYX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 407000.00
SCYX balance_sheet (annual, 2024-12-31) — Current Debt: 13688000.00
SCYX balance_sheet (quarterly, 2024-12-31) — Current Debt: 13688000.00
SCYX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 14095000.00
SCYX balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 1642000.00
SCYX balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 1642000.00
SCYX balance_sheet (annual, 2024-12-31) — Current Liabilities: 24099000.00
SCYX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 0.00
SCYX cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 0.00
SCYX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 0.00
SCYX cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 0.00
SCYX balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 7998000.00
SCYX income_statement (annual, 2024-12-31) — Diluted Average Shares: 6064134.00
SCYX income_statement (annual, 2024-12-31) — Diluted EPS: -3.52
SCYX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -21288000.00
SCYX income_statement (annual, 2024-12-31) — EBIT: -20309000.00